Health care · Historical news and closing prices
INOVIQ received approximately $2 million in Australian R&D tax incentives for eligible research and development activities in FY26, when it spent $4 million on R&D.
Closing price · 2026-10-26: $0.140 · +3.70%
INOVIQ Limited has announced that CEO Dr. Leearne Hinch will step down, with Chairman Peter Gunzburg stepping in as Executive Chair on an interim basis. The company will begin an executive search for a new CEO while continuing to focus on its exosome-based diagnostics and therapeutics. INOVIQ plans to update the market on its future strategies at the upcoming Annual General Meeting.
Closing price · 2026-10-23: $0.135 · +3.85%